《美国股市》道指升2点 花旗跌近7% 苹果先升後回
美股上升,市场憧憬美联储持续超宽松货币政策,苹果股价在发布会後回落拖累道指。道指高开146点後,早段曾升237点见28,231点,其後升幅收窄,尾市曾倒跌61点,收市前回稳。
道琼斯工业平均指数升2.27点或0.01%,收报27,995.6点。
标准普尔500指数升17.66点或0.5%,收报3,401.2点。
纳斯达克指数升133.67点或1.2%,收报11,190.32点。
卡特彼勒及摩根大通各跌3.2%及3.1%,为跌幅最大道指成分股。Salesforce及陶氏各升2%,为升幅最大道指成分股。花旗集团据报面临监管机构批评机风险监管系统缺失,股价跌6.9%。苹果股价升0.2%,盘中曾升3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.